Medipost designated to develop treatments for major diseases

Published: 2006-12-04 06:56:00

Updated: 2006-12-04 06:56:00

The Ministry of Health and Welfare said it designated Seoul National University Hospital, Seoul Asan Medical Center and Medipost, a local leader in umbilical cord blood use and hematopoietic stem cell research, as innovative medical institutions to fight against major diseases attacking Koreans.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK